RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.470
-0.110 (-6.96%)
At close: Oct 5, 2026, 4:00 PM EDT
1.470
0.00 (0.00%)
Pre-market: Oct 6, 2026, 4:01 AM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $66.34 million as of October 5, 2026. Its market cap has increased by 37.14% in one year.
Market Cap
66.34M
Enterprise Value
57.25M
1-Year Change
37.14%
Ranking
Category
Stock Price
$1.47
ChartMarket Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $66.34M, a decrease of -3.35%. That is a compound annual growth rate of -0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 66.34M | 115.46% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 74.72M |
| Gain Therapeutics | 74.63M |
| NeOnc Technologies Holdings | 74.32M |
| MAIA Biotechnology | 72.38M |
| iBio, Inc. | 72.35M |
| Aldeyra Therapeutics | 70.58M |
| Adicet Bio | 69.97M |
| Spero Therapeutics | 69.30M |